BIST10014.514,82 0.82%Mirasın Şartı: Finansal Okuryazarlık SınavıUSD/TRY48.3406 0.20%Wall Street'te Haftalık Kapanış: Tahvil ve Petrol Baskısına Rağmen Pozitif SeyirEUR/TRY56.2160 0.30%Algoritmik Kararlara Milyon Dolarlık Darbe: Uber İçin Hollanda FreniBTC/USD$77,976.02 7.17%İsviçre Merkez Bankası'ndan Radikal Sinyal: Faizlerde Negatif Dönem Kapıda mı?GRAM ALTIN7.091,08 0.15%BIST 100 Yükselişte: 14.600’e Yaklaşan Kritik Seviyeler ve Sektör DinamikleriBRENT$93.87 0.10%Bitcoin $78,200'e Çıktı, Hyperliquid Kaldıraçlı Ticarette Yeni Güç MerkeziVolkswagen Model Portföyünü Yarıya İndiriyor: Üretim Stratejisindeki Kök DeğişimBIST10014.514,82 0.82%Mirasın Şartı: Finansal Okuryazarlık SınavıUSD/TRY48.3406 0.20%Wall Street'te Haftalık Kapanış: Tahvil ve Petrol Baskısına Rağmen Pozitif SeyirEUR/TRY56.2160 0.30%Algoritmik Kararlara Milyon Dolarlık Darbe: Uber İçin Hollanda FreniBTC/USD$77,976.02 7.17%İsviçre Merkez Bankası'ndan Radikal Sinyal: Faizlerde Negatif Dönem Kapıda mı?GRAM ALTIN7.091,08 0.15%BIST 100 Yükselişte: 14.600’e Yaklaşan Kritik Seviyeler ve Sektör DinamikleriBRENT$93.87 0.10%Bitcoin $78,200'e Çıktı, Hyperliquid Kaldıraçlı Ticarette Yeni Güç MerkeziVolkswagen Model Portföyünü Yarıya İndiriyor: Üretim Stratejisindeki Kök Değişim
Girişimcilik & Startuplar

Daniel Ek’s Neko Health Opens First U.S. Office, Fueling the Body‑Scanning Revolution with $700M Series C

724FinanceDeniz Arslan
Key Highlights

Neko Health’in New York’taki ilk ofisini 24 Eylül’de açarak **Daniel Ek** ve **Hjalmar Nilsonne**’in vücut tarama çığırını atmaya devam ettiği bildiri

Daniel Ek’s Neko Health Opens First U.S. Office, Fueling the Body‑Scanning Revolution with $700M Series C

Neko Health’s first U.S. office opens on September 24, marking Daniel Ek and Hjalmar Nilsonne’s continued push to disrupt body‑scanning technology.

First Footfall in New York: Neko Health Expands to the U.S.

The startup is opening its inaugural Manhattan office at 300 Lafayette Street in SoHo, with 25,000 New Yorkers already on the waitlist.

A $700 Million Series C Propels the Momentum

Last month’s $700 Million Series C round, coupled with 100,000 scans conducted, underscores Neko’s rapid scale potential and sets the stage for aggressive U.S. expansion.

Pushing the Boundaries of Tech‑Health Integration

Neko pairs proprietary body‑scanning tech with bloodwork and fitness‑device data to deliver personalized health assessments. With existing operations in the U.K. and Sweden, the new U.S. office signals a drive toward global reach.

The Competitive Landscape: Midjourney, Fountain Life, Function Health

  • Midjourney: Building a body scanner to integrate into spa experiences
  • Fountain Life: Longevity venture by Tony Robbins and Peter Diamandis
  • Function Health: Wellness platform, recently secured a $450 Million loan from General Catalyst’s Customer Value Fund
  • Operational Targets and Customer Expectations

  • Aim to conduct 500 scans in the first three months
  • Strategic partnerships with U.S. health insurers
  • Commitment to data privacy and GDPR compliance
  • Neko Health’s U.S. launch signals a new era for body‑scanning tech’s integration into medical applications. The company’s robust financing and the backing of a high‑profile founder position it well to capture a growing data‑driven health market, offering investors a compelling blend of innovation and scalability.

    Related News & Analysis

    View All →

    Latest Market News

    All News →
    D

    Financial Analyst: Deniz Arslan

    Risk Sermayesi (VC) Ortağı ve Girişimcilik Mentoru. Startupların fonlanma turlarını, değerlemelerini, yapay zeka girişimlerini ve teknoloji unicornlarını analiz eden teknoloji yatırımcısı.

    Disclaimer: The investment information, comments, and recommendations contained herein are not within the scope of investment advisory. Investment advisory services are provided individually by authorized institutions, taking into account the risk and return preferences of individuals. The comments and recommendations contained herein are general in nature. These recommendations may not be suitable for your financial situation and your risk and return preferences. Therefore, making an investment decision based solely on the information contained herein may not produce results that meet your expectations.

    © 2026 724Finance - All Rights Reserved.Original Source: News.google.com